You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HRTX Exercise Disclosure
Forbes William P · SEC Form 4 · Filed Jun 8, 2026
Exercise
Reported value range
Not reported
Forbes William P EVP, Chief Development Officer
HRTX
Heron Therapeutics
HRTX
Transaction date
Jun 6, 2026
Public filing date
Jun 8, 2026
Filing lag
Filed 2 days later
HRTX daily price context
Close on/before transaction
$0.43
Jun 5, 2026
First close after public filing
$0.4
Jun 9, 2026
30-day return after filing
+10.03%
Through Jul 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 12,500 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-260931
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Heron Therapeutics, Inc. /de/ HRTX Current | Exercise | Jun 6, 2026 | Not reported |
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Jun 6, 2026 | $0 |